Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice

Neuroscience Letters

Volumn 442, Issue 2, 2008, Pages 100-103

  Schulte Herbrüggen, Olaf ^a   Hörtnagl, Heide ^a   Ponath, Gerald ^b   Rothermundt, Matthias ^b   Hellweg, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

BDNF; Dopamine; NGF; Noradrenaline; S100B; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NERVE GROWTH FACTOR; NORADRENALIN; PROTEIN S100B; SEROTONIN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; FEMALE; FRONTAL CORTEX; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; KNOCKOUT MOUSE; MOUSE; NEOCORTEX; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; SEROTONIN BRAIN LEVEL; SEROTONINERGIC NERVE CELL;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE EXPRESSION REGULATION; HYDROXYINDOLEACETIC ACID; MICE; MICE, KNOCKOUT; NERVE GROWTH FACTORS; NOREPINEPHRINE; S100 PROTEINS; SEROTONIN;

EID: 48149094910     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.07.013     Document Type: Article

References (41)

1. Azmitia E.C., Dolan K., and Whitaker-Azmitia P.M. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor. Brain Res. 516 (1990) 354-356
2. Chourbaji S., Vogt M.A., Fumagalli F., Sohr R., Frasca A., Brandwein C., Hörtnagl H., Riva M.A., Sprengel R., and Gass P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J. (2008) [Epub ahead of print]
3. Dietrich D.E., Hauser U., Peters M., Zhang Y., Wiesmann M., Hasselmann M., Rudolf S., Jungling O., Kirchner H., Munte T.F., Arolt V., Emrich H.M., Johannes S., and Rothermundt M. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression. Neurosci. Lett. 354 (2004) 69-73
4. Djalali S., Holtje M., Grosse G., Rothe T., Stroh T., Grosse J., Deng D.R., Hellweg R., Grantyn R., Hörtnagl H., and Ahnert-Hilger G. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J. Neurochem. 92 (2005) 616-627
5. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33 (2001) 637-668
6. Esposito G., Imitola J., Lu J., De F.D., Scuderi C., Ganesh V.S., Folkerth R., Hecht J., Shin S., Iuvone T., Chesnut J., Steardo L., and Sheen V. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum. Mol. Genet. 17 (2008) 440-457
7. Felice L.J., Felice J.D., and Kissinger P.T. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 31 (1978) 1461-1465
8. Gallinat J., Muller D.J., Bierbrauer J., Rommelspacher H., Juckel G., and Wernicke C. Functional cortical effects of novel allelic variants of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) in humans. Pharmacopsychiatry 40 (2007) 191-195
9. Galter D., and Unsicker K. Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol. Cell. Neurosci. 15 (2000) 446-455
10. Grabe H.J., Ahrens N., Rose H.J., Kessler C., and Freyberger H.J. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 44 (2001) 88-90
11. Grosse G., Djalali S., Deng D.R., Holtje M., Hinz B., Schwartzkopff K., Cygon M., Rothe T., Stroh T., Hellweg R., hnert-Hilger G.A., and Hörtnagl H. Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain. Dev. Brain Res. 156 (2005) 111-126
12. Hellweg R., Gericke C.A., Jendroska K., Hartung H.D., and Cervos-Navarro J. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int. J. Dev. Neurosci. 16 (1998) 787-794
13. Hellweg R., Hock C., and Hartung H.D. An improved rapid and highly sensitive enzyme immunoassay for nerve growth factor. Tech. J. Methods Cell. Mol. Biol. 1 (1989) 43-48
14. Hellweg R., Lohmann P., Huber R., Kühl A., and Riepe M.W. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn. Mem. 13 (2006) 63-71
15. Hellweg R., von Arnim C.A., Buchner M., Huber R., and Riepe M.W. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. Exp. Neurol. 183 (2003) 346-354
16. Lang U.E., Jockers-Scherübl M.C., and Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J. Neural Transm. 111 (2004) 387-411
17. Liu J.P., and Lauder J.M. S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33 (1992) 248-256
18. Ma Y.T., Hsieh T., Forbes M.E., Johnson J.E., and Frost D.O. BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death. J. Neurosci. 18 (1998) 2097-2107
19. Mamounas L.A., Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., and Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci. 20 (2000) 771-782
20. Martin-Iverson M.T., Todd K.G., and Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J. Neurosci. 14 (1994) 1262-1270
21. Nishi M., Kawata M., and Azmitia E.C. Trophic interactions between brain-derived neurotrophic factor and s100beta on cultured serotonergic neurons. Brain Res. 868 (2000) 113-118
22. Nishiyama H., Takemura M., Takeda T., and Itohara S. Normal development of serotonergic neurons in mice lacking S100B. Neurosci. Lett. 321 (2002) 49-52
23. Parker T.G., Marks A., and Tsoporis J.N. Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy. Can. J. Appl. Physiol 23 (1998) 377-389
24. Pedersen A., Siegmund A., Ohrmann P., Rist F., Rothermundt M., Suslow T., and Arolt V. Reduced implicit and explicit sequence learning in first-episode schizophrenia. Neuropsychologia 46 (2008) 186-195
25. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., Rudolf S., and Kirchner H. S-100B is increased in melancholic but not in non-melancholic major depression. J. Affect. Disord. 66 (2001) 89-93
26. Rothermundt M., Peters M., Prehn J.H., and Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60 (2003) 614-632
27. Ruhe H.G., Mason N.S., and Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12 (2007) 331-359
28. Rumajogee P., Verge D., Darmon M., Brisorgueil M.J., Hamon M., and Miquel M.C. Rapid up-regulation of the neuronal serotoninergic phenotype by brain-derived neurotrophic factor and cyclic adenosine monophosphate: relations with raphe astrocytes. J. Neurosci. Res. 81 (2005) 481-487
29. Sarandol A., Kirli S., Akkaya C., Altin A., Demirci M., and Sarandol E. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1164-1169
30. Schroeter M.L., bdul-Khaliq H., Diefenbacher A., and Blasig I.E. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport 13 (2002) 1675-1678
31. Schulte-Herbrüggen O., Braun A., Rochlitzer S., Jockers-Scherübl M.C., and Hellweg R. Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?. Curr. Med. Chem. 14 (2007) 2318-2329
32. Spenger C., Hyman C., Studer L., Egli M., Evtouchenko L., Jackson C., Dahl-Jorgensen A., Lindsay R.M., and Seiler R.W. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp. Neurol. 133 (1995) 50-63
33. Sperk G. Simultaneous determination of serotonin, 5-hydroxindoleacetic acid, 3,4-dihydroxyphenylacetic acid and homovanillic acid by high performance liquid chromatography with electrochemical detection. J. Neurochem. 38 (1982) 840-843
34. Sperk G., Berger M., Hörtnagl H., and Hornykiewicz O. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat. Eur. J. Pharmacol. 74 (1981) 279-286
35. Tsoporis J.N., Marks A., Zimmer D.B., McMahon C., and Parker T.G. The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart. Mol. Cell. Biochem. 242 (2003) 27-33
36. Ueda S., Gu X.F., Whitaker-Azmitia P.M., Naruse I., and Azmitia E.C. Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). I. Immunocytochemical and neurochemical studies. Brain Res. 633 (1994) 275-283
37. Ueda S., Hou X.P., Whitaker-Azmitia P.M., and Azmitia E.C. Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). II. Co-cultures study. Brain Res. 633 (1994) 284-288
38. Ueda S., Kokotos Leonardi E.T., Bell III J., and Azmitia E.C. Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100 beta antisense gene, Mol. Brain Res. 29 (1995) 365-368
39. von Bartheld C.S., Williams R., Lefcort F., Clary D.O., Reichardt L.F., and Bothwell M. Retrograde transport of neurotrophins from the eye to the brain in chick embryos: roles of the p75NTR and trkB receptors. J. Neurosci. 16 (1996) 2995-3008
40. Whitaker-Azmitia P.M., Murphy R., and Azmitia E.C. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 528 (1990) 155-158
41. Xiong Z., O'Hanlon D., Becker L.E., Roder J., MacDonald J.F., and Marks A. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp. Cell Res. 257 (2000) 281-289